Beyond the Basics: Advancements in the Drug Screening Market

The drug screening market was estimated at USD 6.13 billion in 2022 and is likely to grow at a CAGR of 16.7% during 2023-2028 to reach USD 15.52 billion in 2028.

Drug screening is defined as the process of collecting and analyzing blood, hair, urine, or saliva to detect the presence of contaminants and chemicals left in the body as a result of drug consumption. In this process, potential drugs are identified and optimized before selecting a candidate drug for a clinical trial. Drug screening is done in order to determine if a person is or has consumed drugs at a certain point in time.